IDH-mutant Grade 2 or 3 Astrocytoma
1 clinical trials · Condition
◉ Watch IDH-mutant Grade 2 or 3 Astrocytoma
| Record | Firm | Date |
|---|---|---|
| Vorasidenib Maintenance for IDH Mutant Astrocytoma (NCT06809322) | European Organisation for Research and Treatment of Cancer - EORTC | 2026-01-16 |
Track IDH-mutant Grade 2 or 3 Astrocytoma automatically
Every clearance here is in the API, with alerts when new ones post.